Orally Active Isoxazoline GPIIb/IIIa Antagonists
Open Access
- 1 March 1998
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 16 (1) , 48-61
- https://doi.org/10.1111/j.1527-3466.1998.tb00344.x
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Nonpeptide glycoprotein IIb/IIIa inhibitors: 18. Indole alpha-sulfonamide acids are potent inhibitors of platelet aggregationBioorganic & Medicinal Chemistry Letters, 1997
- Nonpeptide glycoprotein IIb/IIIa inhibitors. 13. design and synthesis of an orally active pyrazolopiperazinone nonpeptide fibrinogen receptor antagonistBioorganic & Medicinal Chemistry Letters, 1997
- Discovery of an Orally Active Series of Isoxazoline Glycoprotein IIb/IIIa AntagonistsJournal of Medicinal Chemistry, 1997
- Novel nonpeptide antiplatelet glycoprotein llb/llla receptor antagonist, DMP754Coronary Artery Disease, 1996
- Novel antithrombotic approaches to coronary artery diseaseThe American Journal of Cardiology, 1995
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- Fibrinogen receptor antagonists containing a gamma-lactam Gly-Asp isostereBioorganic & Medicinal Chemistry Letters, 1993
- Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.Journal of Clinical Investigation, 1988
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Platelet Membrane Glycoprotein IIb/IIIa: Member of a Family of Arg-Gly-Asp—Specific Adhesion ReceptorsScience, 1986